HiDAC: Clinical Trials

2 trials of HiDAC, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 terminated. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Terminated 1

Follow HiDAC: new trials by email Literature Review of HiDAC trials Research Report on HiDAC

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Revumenib in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias
Revumenib, Chemotherapy Regimen, HiDAC - Acute Myeloid Leukemias
Phase 1Active not recruitingSyndax Pharmaceuticals962024-05-212026-09-16
Ficlatuzumab With High Dose Cytarabine in Relapsed and Refractory AML
Ficlatuzumab, Cytarabine - Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia
Phase 1TerminatedC. Babis Andreadis172015-05-012020-03-24

Conditions studied

Leukemia, Myeloid, Acute (2)

Sponsors

C. Babis Andreadis (1)  ·  Syndax Pharmaceuticals (1)

Countries

United States (2)  ·  Australia (1)  ·  Canada (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Charalambos Andreadis, MD (1)